Myocardial Stunning

Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.

September 7, 2021

Neurogenic Stunned Myocardium: A Review.

AACN Advanced Critical Care
Amy Stoddard, Donna Lynch-Smith
August 14, 2021

A Retinoic Acid Receptor β 2 Agonist Improves Cardiac Function in a Heart Failure Model.

The Journal of Pharmacology and Experimental Therapeutics
Xiao-Han TangRoberto Levi
August 14, 2021
Review

Pathophysiology of Takotsubo Cardiomyopathy: Reopened Debate.

Texas Heart Institute Journal
Paolo AngeliniJonathan M Tobis
August 9, 2021

Changes in Global Left Ventricular Myocardial Work Indices and Stunning Detection 3 Months After ST-Segment Elevation Myocardial Infarction.

The American Journal of Cardiology
Rodolfo P LustosaJeroen J Bax
August 7, 2021
Review
Open Access

Takotsubo Cardiomyopathy: Current Treatment.

Journal of Clinical Medicine
John E Madias
July 13, 2021
Review

A Comparison of Hemodialysis and Peritoneal Dialysis in Patients with Cardiovascular Disease.

Cardiology Clinics
Rehab B Albakr, Joanne M Bargman
July 6, 2021
Comment / Editorial
Open Access

Spinning the legs and blood: should intradialytic exercise be routinely offered during maintenance haemodialysis?

Clinical Kidney Journal
Matthew P M Graham-BrownJames O Burton
July 6, 2021
Open Access

Postoperative Cardiac Arrest in Cardiac Surgery-How to Improve the Outcome?

Medical Archives
Ashraf Fadel Moh'dSalah E Altarabsheh
June 19, 2021

Increased nitric oxide availability worsens the cardiac performance during early re-perfusion period in adult rats.

Journal of Basic and Clinical Physiology and Pharmacology
Faten M A DiabEnas A Abdel-Hady
June 9, 2021
Open Access

Assessment of stunned and viable myocardium using manganese-enhanced MRI.

Open Heart
Nick B SpathScott Semple
June 5, 2021
Open Access

Loss of PKA regulatory subunit 1α aggravates cardiomyocyte necrosis and myocardial ischemia/reperfusion injury.

The Journal of Biological Chemistry
Yuening LiuZhaokang Cheng
June 5, 2021
Review

Coronary microvascular dysfunction in Takotsubo syndrome: cause or consequence.

American Journal of Cardiovascular Disease
Shams Y-Hassan
June 3, 2021
Open Access

Hydrogen sulfide donor protects against mechanical ventilation-induced atrophy and contractile dysfunction in the rat diaphragm.

Clinical and Translational Science
Noriko Ichinoseki-SekineScott K Powers
June 3, 2021
Open Access

Remifentanil protects against myocardial ischemia/reperfusion injury via miR-205-mediated regulation of PINK1.

The Journal of Toxicological Sciences
Lu ChengChunyan Jian
June 3, 2021
Review
Open Access

The Defibrillation Conundrum: New Insights into the Mechanisms of Shock-Related Myocardial Injury Sustained from a Life-Saving Therapy.

International Journal of Molecular Sciences
Nicolas ClementyDominique Babuty
May 24, 2021
Comment / Editorial

Intradialytic hypotension: is timing everything?

Kidney International
Peter SohnConnie M Rhee

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused by a partial deletion of chromosome 22. Symptoms include heart defects, poor immune system function, a cleft palate, complications related to low levels of calcium in the blood, and delayed development. Discover the latest research on this disease here.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Arrhythmogenic Right Ventricular Dysplasia

Arrhythmogenic right ventricular dysplasia is a congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the right ventricle wall and loss of myocardial cells. Primary injuries usually are at the free wall of the right ventricular and right atria resulting in ventricular and supraventricular arrhythmias. Discover the latest research on arrhythmogenic right ventricular dysplasia here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

© 2021 Meta ULC. All rights reserved
/feed-previews/myocardial-stunning/29ad646d-5933-4493-81ee-5d25265b8238